Inspections, Compliance, Enforcement, and Criminal Investigations

May 20, 2015: Telemarketer Sentenced For Role In Marketing Non-FDA Approved Drugs In United States

 

OCI Small Clear Seal 

 


 

 

 

Food and Drug Administration 
Office of Criminal Investigations

 


 

 

             U.S. Department of Justice Press Release

 

 

For Immediate Release
May 20, 2015

United States Department of Justice

Middle District of Florida

Tampa, FL – U.S. District Judge Mary S. Scriven today sentenced Naresh Kumar Chintala (33, India) to 30 months in federal prison for conspiracy to commit wire fraud and to dispense prescription drugs without a prescription. He pleaded guilty on February 23, 2015.

  

According to court documents, Chintala worked for an India-based company that marketed drugs, both prescription and otherwise, to customers in the United States by means of telemarketing. The representations made by the marketers about these drugs claimed that the drugs were made in the United States and FDA-approved. In reality, the drugs were neither. In some instances, the drugs sold through this marketing scheme were prescription medications, but the company required no medical prescription for the sale. The medications ordered by the customers were shipped to them from India, in parcels bearing false labels as to the nature of their contents. Chintala traveled to the United States in late 2014 on company business and was arrested in Jacksonville, Florida.

 

This case was investigated by the United States Food and Drug Administration. It was prosecuted by Assistant United States Attorneys Jay L. Hoffer and Mark Bini.

 

 

 

 

 

 

Page Last Updated: 05/21/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English